Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.

Locklear JC, Svedsäter H, Datto C, Endicott J.

J Affect Disord. 2013 Jul;149(1-3):189-95. doi: 10.1016/j.jad.2013.01.021. Epub 2013 Apr 29.

PMID:
23639212
[PubMed - indexed for MEDLINE]
2.

Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.

Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C.

Am J Geriatr Psychiatry. 2013 Aug;21(8):769-84. doi: 10.1016/j.jagp.2013.01.010. Epub 2013 Feb 6.

PMID:
23567397
[PubMed - indexed for MEDLINE]
3.

Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.

Trivedi MH, Bandelow B, Demyttenaere K, Papakosts GI, Szamosi J, Earley W, Eriksson H.

Int J Neuropsychopharmacol. 2013 Sep;16(8):1733-44. doi: 10.1017/S146114571300028X. Epub 2013 May 14.

PMID:
23673347
[PubMed - indexed for MEDLINE]
4.

Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.

Bauer M, McIntyre RS, Szamosi J, Eriksson H.

Int J Neuropsychopharmacol. 2013 Sep;16(8):1755-65. doi: 10.1017/S146114571300031X. Epub 2013 May 14.

PMID:
23672772
[PubMed - indexed for MEDLINE]
5.

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.

Mezhebovsky I, Mägi K, She F, Datto C, Eriksson H.

Int J Geriatr Psychiatry. 2013 Jun;28(6):615-25. doi: 10.1002/gps.3867. Epub 2012 Oct 16.

PMID:
23070803
[PubMed - indexed for MEDLINE]
6.

Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.

Montgomery SA, Altamura AC, Katila H, Datto C, Szamosi J, Eriksson H.

Int Clin Psychopharmacol. 2014 Mar;29(2):93-105. doi: 10.1097/YIC.0000000000000007.

PMID:
24162081
[PubMed - indexed for MEDLINE]
7.

Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.

Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H.

Depress Anxiety. 2010 Oct;27(10):964-76. doi: 10.1002/da.20740.

PMID:
20734365
[PubMed - indexed for MEDLINE]
8.

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.

El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H.

Int J Neuropsychopharmacol. 2010 Aug;13(7):917-32. doi: 10.1017/S1461145710000015. Epub 2010 Feb 23.

PMID:
20175941
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder.

Wang G, McIntyre A, Earley WR, Raines SR, Eriksson H.

Neuropsychiatr Dis Treat. 2014 Jan 30;10:201-16. doi: 10.2147/NDT.S50248. eCollection 2014.

PMID:
24511235
[PubMed]
Free PMC Article
10.

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder.

Endicott J, Svedsäter H, Locklear JC.

Neuropsychiatr Dis Treat. 2012;8:301-11. doi: 10.2147/NDT.S32320. Epub 2012 Jul 11.

PMID:
22848184
[PubMed]
Free PMC Article
11.

Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.

Sheehan DV, Locklear J, Svedsäter H, Datto C.

Int Clin Psychopharmacol. 2012 Sep;27(5):239-48. doi: 10.1097/YIC.0b013e328356ac78.

PMID:
22859063
[PubMed - indexed for MEDLINE]
12.

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.

Weisler RH, Montgomery SA, Earley WR, Szamosi J, Lazarus A.

Int Clin Psychopharmacol. 2012 Jan;27(1):27-39. doi: 10.1097/YIC.0b013e32834d6f91.

PMID:
22027845
[PubMed - indexed for MEDLINE]
13.

Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.

Thase ME, Demyttenaere K, Earley WR, Gustafsson U, Udd M, Eriksson H.

Depress Anxiety. 2012 Jul;29(7):574-86. doi: 10.1002/da.21970. Epub 2012 Jul 2.

PMID:
22753280
[PubMed - indexed for MEDLINE]
14.

Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.

Weisler R, Montgomery SA, Earley WR, Szamosi J, Eriksson H.

J Clin Psychiatry. 2014 May;75(5):520-7. doi: 10.4088/JCP.13m08624.

PMID:
24816198
[PubMed - indexed for MEDLINE]
15.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079. Epub 2013 Jun 27.

PMID:
23810357
[PubMed - indexed for MEDLINE]
16.

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.

Stein DJ, Bandelow B, Merideth C, Olausson B, Szamosi J, Eriksson H.

Hum Psychopharmacol. 2011 Dec;26(8):614-28. doi: 10.1002/hup.1256. Epub 2011 Dec 6.

PMID:
22143997
[PubMed - indexed for MEDLINE]
17.

A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder.

Khan A, Joyce M, Atkinson S, Eggens I, Baldytcheva I, Eriksson H.

J Clin Psychopharmacol. 2011 Aug;31(4):418-28. doi: 10.1097/JCP.0b013e318224864d.

PMID:
21694613
[PubMed - indexed for MEDLINE]
18.

Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study.

Sheehan DV, Svedsäter H, Locklear JC, Eriksson H.

J Affect Disord. 2013 Dec;151(3):906-13. doi: 10.1016/j.jad.2013.07.037. Epub 2013 Aug 16.

PMID:
24135509
[PubMed - indexed for MEDLINE]
19.

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group.

CNS Spectr. 2009 Jun;14(6):299-313.

PMID:
19668121
[PubMed - indexed for MEDLINE]
20.

Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.

Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.

J Affect Disord. 2008 Dec;111(2-3):306-19. doi: 10.1016/j.jad.2008.06.019. Epub 2008 Sep 5.

PMID:
18774180
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk